These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473 [No Abstract] [Full Text] [Related]
33. Renal transplantation in children less than six years old. Garcia CD; Barros V; Schneider L; Guimarães P; Didone E; Guerra EE; Vitola SP; Garcia VD Transplant Proc; 2001; 33(7-8):3595-6. PubMed ID: 11750527 [No Abstract] [Full Text] [Related]
34. Treatment of cytomegalovirus infections with gancyclovir during OKT3 administration. Haberal M; Velidedoğlu E; Arslan G; Bilgin N; Büyükpamukçu N; Karamehmetoğlu M Transplant Proc; 1995 Oct; 27(5):2707. PubMed ID: 7482883 [No Abstract] [Full Text] [Related]
35. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
36. Preventive OKT3 treatment with cyclosporine (Sandimmun) for second kidney transplantation. Perner F; Alföldy F; Járay J; Hidvégi M; Hemangshu P Transpl Int; 1994; 7 Suppl 1():S255-8. PubMed ID: 11271218 [TBL] [Abstract][Full Text] [Related]
37. A drug of the past, a lesson for the future. Vincenti F Pediatr Transplant; 2005 Jun; 9(3):267-8. PubMed ID: 15910379 [No Abstract] [Full Text] [Related]